??Dysmenorrhea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: First group in first month of period will receive 400 mg ibuprofen tablets with placebo during a period of 3 days from the onset of menstruation and second group over a period of 3 day
Treatment - Drugs
First group in first month of period will receive 400 mg ibuprofen tablets with placebo during a period of 3 days from the onset of menstruation and second group over a period of 3 days in the same mo
In the second month of menstruation the two group treatment drug regime will exchange, thus the first group will treated with a combination of ibuprofen –alprazolam and to second group will be given i
Sponsors
Research Chanseller of Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ; primary moderate to severe estabilished dysmenorrheal ; regular menstruation cycle ; being single; 18-25 years old Exclusion criteria:; Pregnancy ; gasterointestinal problems and ulcer peptic history ; affect disorders ; renal and hepatic disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal pain- low back pain and other symptoms of dysmenorrhea. Timepoint: Variables for each of two consecutive menstrual cycles before treatment, on the second and fourth days of treatment are measured. Method of measurement: Dysmenorrhea side effects will assess by using COX questionare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahmoud Baradaran
Babol University of Medical Sciences
Outcome results
None listed